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A 47-year-old garage proprietor presented with a three-month history of numbness and tingling of his feet and subsequently of both hands. These symptoms were accompanied by a sensation of electric shocks in his arms and legs, precipitated by forward flexion of the neck. There was no history of trauma to the cervical spine and he had previously been in good health.
General physical examination was normal. It is generally accepted that Lhermitte's sign results from damage to the sensory pathways in the cervical cord and is most commonly found in multiple sclerosis and also in vitamin B12 deficiency.6'7 The common pathological mechanism of these two conditions is demyelination which has been well described in vitamin B12 deficiency.8 Animal studies confirm that demyelinated axons are stimulated by mechanical deformation.9 In the human, similar deformation of the cervical cord occurs during neck flexion resulting in excitation of demyelinated axons.
The present case is remarkable in that Lhermitte's sign was encountered without any indications of posterior column disease and with a normal vitamin B12 level. We postulate that the moderate co-existant subluxation of the cervical spine during flexion deformed the spinal cord more than usual, and thus generated excitation in only mildly demyelinated sensory neurones. Treatment with vitamin B12 reversed the demyelination, resulting in clinical resolution of the dysaesthesia and Lhermitte's sign, despite the persistent bony abnormalities of the cervical spine.
It has been recognised for many years that the neurological complications of vitamin B12 deficiency may precede or occur without haematological abnormalities, but it is also becoming apparent that neurological disease may occur with normal vitamin B12 levels.'0 This case confirms that a normal vitamin B12 level does not exclude vitamin B12 deficiency, and demonstrates the importance of proceeding to further investigation including a Schilling test if early diagnosis and treatment are to prevent irreversible neurological damage. Patients presenting with Lhermitte's sign who do not have clear evidence of multiple sclerosis should have vitamin B12 deficiency excluded.
